We currently investigated the relationship between δ-catenin and EGFR in order to delineate the potential connection between the enhanced EGFR expression in hormone refractory prostate cancer and the reciprocity of increased δ-catenin and decreased p120ctn expression during late stage prostate cancer. The gene discussed is EGFR; the disease is prostate carcinoma.